GCAN
Greater Cannabis Company, Inc.
Key Financials
Operating Income
$-183005
↓ 17.1%
Net Income
$-331612
↓ 85.2%
Revenue
$7120
↓ 92.5%
Total Liabilities
$742464.00
↓ 17.3%
Shareholders' Equity
$-741649.00
↑ 11.7%
Cash & Equivalents
$166859.00
↓ 38.2%
Operating Cash Flow
$-60153.00
↑ 45.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/13/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 8-K | 10/27/2025 | View on SEC |
| 8-K/A | 10/16/2025 | View on SEC |
| 8-K | 10/15/2025 | View on SEC |
| 10-Q | 8/8/2025 | View on SEC |
| 10-Q/A | 8/8/2025 | View on SEC |
| UPLOAD | 5/22/2025 | View on SEC |
| DEF 14C | 5/16/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GCAN |
| Company Name | Greater Cannabis Company, Inc. |
| CIK | 1695473 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | (443) 738-4051 |